|
IMU
IMU
IMU - Imuniti Holdings Limited - Proposed dual listing on the AIM Market of the
London Stock Exchange
IMUNITI HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration Number 2004/002282/06)
Share code: IMU ISIN: ZAE000089199
("Imuniti" or the "Company")
PROPOSED DUAL LISTING ON THE AIM MARKET OF THE LONDON STOCK EXCHANGE
Imuniti Holdings Limited is pleased to announce that it intends to seek an
admission of its shares to trading on the AIM Market of the London Stock
Exchange ("AIM").
In order to pursue this listing, the company requires South African Reserve Bank
("SARB") approval. SARB approval will not be granted until such time as Imuniti
shareholders have been notified of the company`s intention to seek a dual
listing on AIM.
Therefore the purpose of this announcement is to notify shareholders and satisfy
the SARB request, in order that the company may compile its Reserve Bank
application and submit same, and once it has received SARB approval, proceed
with the application for a dual listing.
The company has not yet approached the London Stock Exchange nor AIM for
approval for the proposed listing, and such approval has therefore not yet been
granted.
The results of the clinical trials which were announced on SENS on 23 March 2011
has initiated various talks with AIDS funding organisations in addition to the
already existing partnership that Edge to Edge Global Investments Limited
("E2E") has with the African Forum . Treatment for vast amounts of AIDS victims
who live in Africa is being supported by these funding organisations.
Imuniti Holdings Limited has signed an exclusive manufacturing agreement with
E2E for the Imuniti Nutritional Supplement Combo ("ISCP") as per the
announcement on SENS dated 14 June 2011, which is the product used in these
clinical trials.
The funding organisations will assist in the roll-out of the Distribution Units
for the ISCP across South Africa initially. This will result in a large
increase in the manufacture of the ISCP by the company and the working capital
and capital expenditure required for this will be provided by the capital raised
on the dual listing.
With the listing on AIM, the company believes it will benefit from improved
access to global investors and global institutional support in the United
Kingdom ("UK").
UK and European institutional investors are very strong supporters of African
focused companies. The proposed AIM listing would allow UK and European
shareholders to trade more freely in the company`s shares.
Durban
22 June 2011
Designated Advisor
Arcay Moela Sponsors (Proprietary) Limited
Date: 22/06/2011 14:41:13 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
| Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information. | |||||||||||||
| Other Profile Group sites: FundsData Online (unit trust data) | Profile Group corporate site | |||||||||||||
| [ Terms of Use | Privacy Policy | PAIA manual | FAQs/Help | Site Map | © Copyright Reserved 2026 ] | |||||||||||||
|
|||||||||||||
